UBS ASSET MANAGEMENT AMERICAS LLC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 1 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$21,013,000
-63.5%
121,598
-75.7%
0.02%
-63.6%
Q4 2014$57,621,000
+935.0%
501,317
+1307.0%
0.06%
+816.7%
Q3 2014$5,567,000
+28.1%
35,629
+1.1%
0.01%
+50.0%
Q2 2014$4,345,000
+20.1%
35,229
+0.9%
0.00%0.0%
Q1 2014$3,619,000
-92.6%
34,929
-93.6%
0.00%
-92.9%
Q4 2013$49,162,000
+19.6%
546,608
-11.0%
0.06%
+9.8%
Q3 2013$41,097,000
-18.7%
614,489
-19.6%
0.05%
-21.5%
Q2 2013$50,578,000764,5950.06%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
MONETARY MANAGEMENT GROUP INC 300$52,0000.02%
View complete list of SALIX PHARMACEUTICALS INC shareholders